ArticleFrontiers in allergy2026
Granular parakeratosis associated with the use of laundry sanitizers containing benzalkonium chloride: a case report.
Article in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Granular parakeratosis (GP) is a rare benign inflammatory dermatosis that preferentially involves the axillae and other intertriginous, friction-prone skin sites and typically presents with pruritic erythema and scaling. Cases associated with benzalkonium chloride (BAC) exposure have rarely been systematically summarized, and further clinical evidence is needed. Herein, we report a case of generalized GP potentially associated with long-term exposure to a BAC-containing laundry sanitizer, with the aim of expanding the clinical spectrum of cutaneous adverse reactions associated with BAC. Case presentation: A 43-year-old Asian man presented with a persistent rash on the trunk and intertriginous areas for more than 1 year. He had a long-standing history of eczema with possible underlying skin-barrier dysfunction but no confirmed diagnosis of atopic dermatitis. He had regularly used a commercial laundry sanitizer containing BAC (0.5 g/L) for clothing disinfection since June 2020, at a frequency of 1-3 times per week. The first rash appeared in July 2021, approximately 13 months after the start of exposure, initially involving the groin and subsequently spreading symmetrically to the neck, axillae, antecubital fossae, lateral waist, back (with sparing of the spinal midline), and undergarment-covered areas. Fungal microscopy and periodic acid-Schiff (PAS) staining were negative. Histopathology showed epidermal hyperkeratosis with characteristic granular parakeratosis, intracorneal pustule formation, neutrophil aggregation, and superficial dermal perivascular inflammatory infiltrates. Direct immunofluorescence for IgG, IgA, IgM, and C3 was negative. In August 2023, the patient completely discontinued the BAC-containing laundry sanitizer, repeatedly rinsed all garments with clean water, and used topical emollients for skin-barrier repair. The lesions gradually subsided and achieved complete clinical remission in September 2023, approximately 1 month after the intervention. No recurrence was observed during 1 year of follow-up. Conclusions: Exposure to BAC-containing laundry sanitizer may be a potential trigger for generalized GP in susceptible individuals. A history of eczema and associated skin-barrier dysfunction may increase susceptibility to irritant exposure. Avoidance of suspected irritants together with skin-barrier repair may be effective in the management of BAC-associated GP. Further prospective studies and confirmatory testing are needed to clarify the causal relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.